Montes Archimedes Acquisition (ROIV)
(Delayed Data from NSDQ)
$10.50 USD
+0.04 (0.38%)
Updated Apr 22, 2024 11:56 AM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Cash flow Statements
Fiscal Year End for Roivant Sciences Ltd falls in the month of March.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -1,115.46 | -924.12 | -900.23 | NA |
Depreciation/Amortization & Depletion | NA | 18.86 | 0.00 | 0.00 | NA |
Net Change from Assets/Liabilities | NA | 6.35 | 15.72 | 6.05 | NA |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | NA | 246.87 | 230.67 | 276.16 | NA |
Net Cash From Operating Activities | NA | -843.39 | -677.73 | -552.14 | NA |
Property & Equipment | NA | -12.69 | -17.44 | -5.81 | NA |
Acquisition/ Disposition of Subsidiaries | NA | -6.71 | 0.00 | 0.00 | NA |
Investments | NA | 114.56 | 320.17 | 0.00 | NA |
Other Investing Activities | NA | -139.43 | 0.56 | -25.90 | NA |
Net Cash from Investing Activities | NA | -44.27 | 303.30 | -31.70 | NA |
Uses of Funds
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 382.84 | 0.00 | 455.76 | NA |
Issuance (Repayment) of Debt | NA | -29.45 | -21.59 | 0.00 | NA |
Increase (Decrease) Short-Term Debt | NA | 159.21 | 36.40 | 0.00 | NA |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | NA | -13.13 | 291.98 | 0.79 | NA |
Net Cash from Financing Activities | NA | 499.46 | 306.79 | 456.26 | NA |
Effect of Exchange Rate Changes | NA | 6.28 | 0.00 | 0.00 | NA |
Net Change In Cash & Equivalents | NA | -381.92 | -67.64 | -127.58 | NA |
Cash at Beginning of Period | NA | 2,074.03 | 2,141.68 | 2,269.25 | NA |
Cash at End of Period | NA | 1,692.12 | 2,074.03 | 2,141.68 | NA |
Diluted Net EPS | NA | -1.42 | -1.26 | NA | NA |
Fiscal Year End for Roivant Sciences Ltd falls in the month of March.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | 4,413.70 | -658.96 | -327.85 | -1,115.46 |
Depreciation/Amortization & Depletion | NA | 16.81 | 11.43 | 5.84 | 18.86 |
Net Change from Assets/Liabilities | NA | 3.08 | -27.39 | -35.24 | 6.35 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | -5,090.40 | 228.56 | 107.32 | 246.87 |
Net Cash From Operating Activities | NA | -656.81 | -446.36 | -249.93 | -843.39 |
Property & Equipment | NA | -1.03 | -0.68 | -0.40 | -12.69 |
Acquisition/ Disposition of Subsidiaries | NA | 5,197.22 | 47.50 | 0.00 | -6.71 |
Investments | NA | 0.00 | 0.00 | 0.00 | 114.56 |
Other Investing Activities | NA | 0.51 | -83.17 | 0.51 | -139.43 |
Net Cash from Investing Activities | NA | 5,196.70 | -36.35 | 0.11 | -44.27 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 490.13 | 242.55 | 21.03 | 382.84 |
Issuance (Repayment) of Debt | NA | -21.82 | -14.47 | -7.34 | -29.45 |
Increase (Decrease) Short-Term Debt | NA | -1.23 | -0.91 | -0.46 | 159.21 |
Payment of Dividends & Other Distributions | NA | -6.00 | -6.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -9.10 | -5.82 | -5.74 | -13.13 |
Net Cash from Financing Activities | NA | 451.99 | 215.35 | 7.48 | 499.46 |
Effect of Exchange Rate Changes | NA | 1.47 | -1.57 | -0.12 | 6.28 |
Net Change In Cash & Equivalents | NA | 4,993.34 | -268.93 | -242.47 | -381.92 |
Cash at Beginning of Period | NA | 1,692.12 | 1,692.12 | 1,692.12 | 2,074.03 |
Cash at End of Period | NA | 6,685.46 | 1,423.19 | 1,449.65 | 1,692.12 |
Diluted Net EPS | NA | 6.03 | -0.40 | -0.38 | -0.03 |